This is the authors' abstract. We don't add key points for this paper.
Background: The detection of chromosomal abnormalities holds significant diagnostic and prognostic value in acute leukemia. While cytogenetics is the standard technique for evaluating ploidy, it is a tedious and labor-intensive process compared to flow cytometry. Flow cytometric determination of leukemic cell DNA content reflects the proliferative index of blast cells. This technique is rapid, cost-effective, sensitive, easy to perform, independent of the tumor's proliferation state, and applicable to nearly all hematological malignancies. Materials and Methods: This study was conducted to determine DNA ploidy in all acute leukemia cases using flow cytometry over a one-year period. A total of 53 new acute leukemia cases were diagnosed based on morphology, special stains, and immunophenotyping. The DNA index was then correlated with other clinico-hematological parameters. Results: In our study, the overall incidence of aneuploidy was 32.07%, with 24% being hyperdiploid and 8% hypoploid. The majority of the aneuploid cases were male (58.8%), while diploid cases showed a female preponderance. We observed that acute lymphoblastic leukemia (ALL) patients with hyperdiploidy demonstrated favorable prognostic factors (i.e., clinico-hematological parameters), whereas hypoploidy was associated with poorer prognostic factors. In acute myeloid leukemia (AML) patients, hyperdiploidy was linked to poor prognostic factors. Conclusion: We recommend that each newly diagnosed case be analyzed by flow cytometry, in addition to karyotyping, for early identification of patients who may benefit from conventional induction therapy.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Gupta et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: